Pegylated interferon alfa-2a/b
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated interferon alfa-2a/b, covering 2016-04-19 to 2016-04-19. Get the full timeline:
Most recent: Clinical Trial Update: 4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients [Phase 1]